Trial Profile
A Phase I, Drug-drug Interaction Study Between Oral Doses of GLPG1205 and a Cocktail of CYP2C9, CYP2C19 and CYP1A2 Substrates in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Mar 2022
Price :
$35
*
At a glance
- Drugs GLPG 1205 (Primary) ; Caffeine; Omeprazole; Warfarin
- Indications Inflammatory bowel diseases; Ulcerative colitis
- Focus Pharmacokinetics
- Sponsors Galapagos NV
- 22 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Dec 2015 New trial record